IDO1 and systemic lupus erythematosus: Compared to the control vector group, Rapa-SLE-EVs with IDO1 knockdown partially reversed the inhibitory effects of Rapa-SLE-EVs on SLE-B cells activation (Fig. 10D–G), proliferation (Fig. 10H and I), and IgG antibody secretion (Fig. 10J).